Racial Disparities in Outpatient Referrals for Opioid Use Disorder Highlighted in Recent Study

A new study highlights racial disparities in outpatient referrals for opioid use disorder, revealing that Black patients are less likely to receive necessary follow-up care after overdose incidents. Efforts are needed to promote equity in emergency department treatment for OUD.
Recent research published in JAMA Network Open uncovers significant racial disparities in the outpatient treatment referral process for individuals who have experienced an opioid overdose. The study analyzed data from 10 hospitals, involving 1,683 patients, to investigate treatment patterns and referrals post-overdose. Findings reveal that only 17.8% of patients received a referral for ongoing outpatient care, while a higher proportion were provided with naloxone kits or prescriptions (42.4%), and a smaller segment received buprenorphine prescriptions (8.4%). Notably, Black patients were significantly less likely to be referred for outpatient treatment compared to white patients, with an adjusted odds ratio of 0.67, indicating a substantial gap in equitable care. Conversely, patients admitted to the hospital were more than three times as likely to receive a referral (adjusted odds ratio of 3.13). The study also identified geographic disparities across different hospital sites. The authors emphasized that these racial disparities in treatment referrals highlight a critical need for targeted interventions to ensure equitable treatment access and address systemic inequities in emergency department care for opioid use disorder (OUD). Addressing these gaps is essential to improving long-term outcomes for minority populations affected by the opioid crisis.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Research Finds No Link Between Childhood Aluminum Vaccines and Risk of Chronic Disorders
A large Danish study shows no link between aluminum in childhood vaccines and increased risk of autoimmune, allergic, or neurodevelopmental disorders, supporting vaccine safety.
Innovative Pulsed Low Dose Rate Chemoradiation Significantly Lowers Side Effects in Cancer Treatment
A cutting-edge pulsed low dose rate chemoradiation therapy has shown promise in reducing side effects for esophageal and lung cancer patients, maintaining treatment effectiveness while improving patient comfort.
Innovative Shape-Shifting Material Could Revolutionize Medical Implants and Ingestible Devices
A groundbreaking metamaterial developed by Rice University researchers offers dynamic shape-shifting capabilities for safer, more effective implantable and ingestible medical devices, promising to revolutionize their design and functionality.



